Background: Increasing evidence for the efficacy of analgesic placebo effects in laboratory studies with healthy persons raises the question whether placebos could be used to improve the treatment of pain patients. Expectancies play a central role in shaping analgesic placebo but also nocebo effects. Objectives: We investigated to what extent a sham opioid infusion (saline solution) produces sustained clinically relevant placebo and nocebo effects in chronic back pain patients. Methods: Fifty-nine patients received the sham opioid infusion applied via a large drain dressing and were compared to 14 control patients without intervention (natural history, NH) while experimental pain stimuli were applied. All subjects were told that the infusion would decrease pain although in rare cases pain increase would be possible (induction of expectancy). In addition, conditioning was introduced where the participants either experienced a decrease in experimental pain (n = 17; placebo conditioning), an increase (n = 21; nocebo conditioning), or no change (n = 21, no conditioning). Results: Compared to the NH group, all infusion groups showed positive treatment expectancies and significantly (p < 0.001) reduced clinical back pain (primary outcome) and pain-related disability (secondary outcome, assessed by self-reported functional capacity and perceived impairment of mobility). Even the nocebo conditioned group experiencing increased experimental pain developed positive treatment expectancies followed by reduced pain experience. Positive treatment expectancies and relief in clinical back pain were significantly positively correlated (r = 0.72, p < 0.01). Conclusions: These findings suggest that it may be beneficial to explicitly shape and integrate treatment expectancies into clinical pain management.

1.
Linde
K
,
Clausius
N
,
Ramirez
G
,
Melchart
D
,
Eitel
F
,
Hedges
LV
, et al.
Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials
.
Lancet
.
1997
Sep
;
350
(
9081
):
834
43
.
[PubMed]
0140-6736
2.
Vase
L
,
Riley
JL
 3rd
,
Price
DD
.
A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia
.
Pain
.
2002
Oct
;
99
(
3
):
443
52
.
[PubMed]
0304-3959
3.
Price
DD
,
Finniss
DG
,
Benedetti
F
.
A comprehensive review of the placebo effect: recent advances and current thought
.
Annu Rev Psychol
.
2008
;
59
(
1
):
565
90
.
[PubMed]
0066-4308
4.
Petrovic
P
.
Placebo analgesia and nocebo hyperalgesia—two sides of the same coin?
Pain
.
2008
May
;
136
(
1-2
):
5
6
.
[PubMed]
0304-3959
5.
Mondaini
N
,
Gontero
P
,
Giubilei
G
,
Lombardi
G
,
Cai
T
,
Gavazzi
A
, et al.
Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?
J Sex Med
.
2007
Nov
;
4
(
6
):
1708
12
.
[PubMed]
1743-6095
6.
Barsky
AJ
,
Saintfort
R
,
Rogers
MP
,
Borus
JF
.
Nonspecific medication side effects and the nocebo phenomenon
.
JAMA
.
2002
Feb
;
287
(
5
):
622
7
.
[PubMed]
0098-7484
7.
Colloca
L
,
Sigaudo
M
,
Benedetti
F
.
The role of learning in nocebo and placebo effects
.
Pain
.
2008
May
;
136
(
1-2
):
211
8
.
[PubMed]
0304-3959
8.
Kaptchuk
TJ
,
Miller
FG
.
Placebo effects in medicine
.
N Engl J Med
.
2015
Jul
;
373
(
1
):
8
9
.
[PubMed]
0028-4793
9.
Evers
AW
,
Colloca
L
,
Blease
C
,
Annoni
M
,
Atlas
LY
,
Benedetti
F
, et al.
Implications of Placebo and Nocebo Effects for Clinical Practice: expert Consensus
.
Psychother Psychosom
.
2018
;
87
(
4
):
204
10
.
[PubMed]
0033-3190
10.
Klinger
R
,
Kothe
R
,
Schmitz
J
,
Kamping
S
,
Flor
H
.
Placebo effects of a sham opioid solution: a randomized controlled study in patients with chronic low back pain
.
Pain
.
2017
Oct
;
158
(
10
):
1893
902
.
[PubMed]
0304-3959
11.
Müller
M
,
Kamping
S
,
Benrath
J
,
Skowronek
H
,
Schmitz
J
,
Klinger
R
, et al.
Treatment history and placebo responses to experimental and clinical pain in chronic pain patients
.
Eur J Pain
.
2016
Oct
;
20
(
9
):
1530
41
.
[PubMed]
1090-3801
12.
Colloca
L
,
Tinazzi
M
,
Recchia
S
,
Le Pera
D
,
Fiaschi
A
,
Benedetti
F
, et al.
Learning potentiates neurophysiological and behavioral placebo analgesic responses
.
Pain
.
2008
Oct
;
139
(
2
):
306
14
.
[PubMed]
0304-3959
13.
Finniss
DG
,
Benedetti
F
.
Mechanisms of the placebo response and their impact on clinical trials and clinical practice
.
Pain
.
2005
Mar
;
114
(
1-2
):
3
6
.
[PubMed]
0304-3959
14.
Enck
P
,
Bingel
U
,
Schedlowski
M
,
Rief
W
.
The placebo response in medicine: minimize, maximize or personalize?
Nat Rev Drug Discov
.
2013
Mar
;
12
(
3
):
191
204
.
[PubMed]
1474-1776
15.
Enck
P
,
Benedetti
F
,
Schedlowski
M
.
New insights into the placebo and nocebo responses
.
Neuron
.
2008
Jul
;
59
(
2
):
195
206
.
[PubMed]
0896-6273
16.
Bąbel
P
,
Bajcar
EA
,
Adamczyk
W
,
Kicman
P
,
Lisińska
N
,
Świder
K
, et al.
Classical conditioning without verbal suggestions elicits placebo analgesia and nocebo hyperalgesia
.
PLoS One
.
2017
Jul
;
12
(
7
):
e0181856
.
[PubMed]
1932-6203
17.
Colloca
L
,
Benedetti
F
.
How prior experience shapes placebo analgesia
.
Pain
.
2006
Sep
;
124
(
1-2
):
126
33
.
[PubMed]
0304-3959
18.
Colloca
L
,
Benedetti
F
.
Placebo analgesia induced by social observational learning
.
Pain
.
2009
Jul
;
144
(
1-2
):
28
34
.
[PubMed]
0304-3959
19.
Colloca
L
,
Petrovic
P
,
Wager
TD
,
Ingvar
M
,
Benedetti
F
.
How the number of learning trials affects placebo and nocebo responses
.
Pain
.
2010
Nov
;
151
(
2
):
430
9
.
[PubMed]
0304-3959
20.
Klinger
R
,
Flor
H
.
Clinical and ethical implications of placebo effects: enhancing patients’ benefits from pain treatment
.
Handb Exp Pharmacol
.
2014
;
225
:
217
35
.
[PubMed]
0171-2004
21.
Fava
GA
,
Guidi
J
,
Rafanelli
C
,
Rickels
K
.
The clinical inadequacy of the placebo model and the development of an alternative conceptual framework
.
Psychother Psychosom
.
2017
;
86
(
6
):
332
40
.
[PubMed]
0033-3190
22.
Faul
F
,
Erdfelder
E
,
Lang
AG
,
Buchner
A
.
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences
.
Behav Res Methods
.
2007
May
;
39
(
2
):
175
91
.
[PubMed]
1554-351X
23.
Koes
BW
,
van Tulder
M
,
Lin
CW
,
Macedo
LG
,
McAuley
J
,
Maher
C
.
An updated overview of clinical guidelines for the management of non-specific low back pain in primary care
.
Eur Spine J
.
2010
Dec
;
19
(
12
):
2075
94
.
[PubMed]
0940-6719
24.
Hautzinger
M
,
Bailer
M
.
Allgemeine Depressions Skala (ADS). Deutsche Form der “Center for Epidemiologic Studies Depression Scale (CES-D)
[
General Depression Scale (ADS). German version of the Center for Epidemiologigic Studies Depression Scale
]
Göttingen
:
Beltz Test GmbH
;
1993
.
25.
Laux
L
,
Spielberger
CD
.
Das State-Trait-Angstinventar: STAI
[
The State-Trait Anxiety Inventory: STAI
]
Göttingen
:
Beltz Test
;
2001
.
26.
Kam-Hansen
S
,
Jakubowski
M
,
Kelley
JM
,
Kirsch
I
,
Hoaglin
DC
,
Kaptchuk
TJ
, et al.
Altered placebo and drug labeling changes the outcome of episodic migraine attacks
.
Sci Transl Med
.
2014
Jan
;
6
(
218
):
218ra5
.
[PubMed]
1946-6234
27.
Bromm
B
,
Meier
W
.
The intracutaneous stimulus: a new pain model for algesimetric studies
.
Methods Find Exp Clin Pharmacol
.
1984
Jul
;
6
(
7
):
405
10
.
[PubMed]
0379-0355
28.
P. B
.
Pain and the brain: from nociception to cognition
.
New York
:
Raven Press
;
1995
.
29.
Pollo
A
,
Vighetti
S
,
Rainero
I
,
Benedetti
F
.
Placebo analgesia and the heart
.
Pain
.
2003
Mar
;
102
(
1-2
):
125
33
.
[PubMed]
0304-3959
30.
Voudouris
NJ
,
Peck
CL
,
Coleman
G
.
The role of conditioning and verbal expectancy in the placebo response
.
Pain
.
1990
Oct
;
43
(
1
):
121
8
.
[PubMed]
0304-3959
31.
Kohlmann
T
,
Raspe
H
.
Der Funktionsfragebogen Hannover zur alltagsnahen Diagnostik der Funktionsbeeinträchtigung durch Rückenschmerzen (FFbH-R)
.
[Hannover functional questionnaire in ambulatory diagnosis of functional disability caused by back-ache]
.
Rehabilitation (Stuttg)
.
1996
Feb
;
35
(
1
):
I
VIII
.
[PubMed]
0034-3536
32.
Roese
I
,
Kohlmann
T
,
Raspe
H
.
[Measuring functional capacity in backache patients in rehabilitation: a comparison of standardized questionnaires]
.
Rehabilitation (Stuttg)
.
1996
May
;
35
(
2
):
103
8
.
[PubMed]
0034-3536
33.
Roland
M
,
Morris
R
.
A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain
.
Spine
.
1983
Mar
;
8
(
2
):
141
4
.
[PubMed]
0362-2436
34.
Voudouris
NJ
,
Peck
CL
,
Coleman
G
.
Conditioned placebo responses
.
J Pers Soc Psychol
.
1985
Jan
;
48
(
1
):
47
53
.
[PubMed]
0022-3514
35.
Voudouris
NJ
,
Peck
CL
,
Coleman
G
.
Conditioned response models of placebo phenomena: further support
.
Pain
.
1989
Jul
;
38
(
1
):
109
16
.
[PubMed]
0304-3959
36.
Montgomery
GH
,
Kirsch
I
.
Classical conditioning and the placebo effect
.
Pain
.
1997
Aug
;
72
(
1-2
):
107
13
.
[PubMed]
0304-3959
37.
Deyo
RA
,
Von Korff
M
,
Duhrkoop
D
.
Opioids for low back pain
.
BMJ
.
2015
Jan
;
350
jan05 10
:
g6380
.
[PubMed]
0959-8138
38.
Blasini
M
,
Corsi
N
,
Klinger
R
,
Colloca
L
.
Nocebo and pain: an overview of the psychoneurobiological mechanisms
.
Pain Rep
.
2017
Mar-Apr
;
2
(
2
):
e585
.
[PubMed]
2471-2531
39.
Klosterhalfen
S
,
Kellermann
S
,
Braun
S
,
Kowalski
A
,
Schrauth
M
,
Zipfel
S
, et al.
Gender and the nocebo response following conditioning and expectancy
.
J Psychosom Res
.
2009
Apr
;
66
(
4
):
323
8
.
[PubMed]
0022-3999
40.
Bartels
DJ
,
van Laarhoven
AI
,
Haverkamp
EA
,
Wilder-Smith
OH
,
Donders
AR
,
van Middendorp
H
, et al.
Role of conditioning and verbal suggestion in placebo and nocebo effects on itch
.
PLoS One
.
2014
Mar
;
9
(
3
):
e91727
.
[PubMed]
1932-6203
41.
Peerdeman
KJ
,
van Laarhoven
A
.
I., Keij, S. M., Vase, L., Rovers, M. M., Peters, M. L., & Evers, A. W.: Relieving patients’ pain with expectation interventions: A meta-analysis
.
J Pain
.
2016
;
157
:
1179
91
. 1526-5900
42.
Colloca
L
,
Finniss
D
.
Nocebo effects, patient-clinician communication, and therapeutic outcomes
.
JAMA
.
2012
Feb
;
307
(
6
):
567
8
.
[PubMed]
0098-7484
43.
Colloca
L
,
Klinger
R
,
Flor
H
,
Bingel
U
.
Placebo analgesia: psychological and neurobiological mechanisms
.
Pain
.
2013
Apr
;
154
(
4
):
511
4
.
[PubMed]
0304-3959
44.
Tekampe
J
,
van Middendorp
H
,
Meeuwis
SH
,
van Leusden
JW
,
Pacheco-López
G
,
Hermus
AR
, et al.
Conditioning immune and endocrine parameters in humans: A systematic review
.
Psychother Psychosom
.
2017
;
86
(
2
):
99
107
.
[PubMed]
0033-3190
45.
Levari
DE
,
Gilbert
DT
,
Wilson
TD
,
Sievers
B
,
Amodio
DM
,
Wheatley
T
.
Prevalence-induced concept change in human judgment
.
Science
.
2018
Jun
;
360
(
6396
):
1465
7
.
[PubMed]
0036-8075
46.
Festinger
L
:
A theory of cognitive dissonance.
Evanston, Il: Row, Peterson
1957
47.
Zanna
MP
,
Cooper
J
.
Dissonance and the pill: an attribution approach to studying the arousal properties of dissonance
.
J Pers Soc Psychol
.
1974
May
;
29
(
5
):
703
9
.
[PubMed]
0022-3514
48.
Totman
R
.
Cognitive dissonance in the placebo treatment of insomnia— a pilot experiment
.
Br J Med Psychol
.
1976
Dec
;
49
(
4
):
393
400
.
[PubMed]
0007-1129
49.
Festinger
L
.
Cognitive dissonance
.
Sci Am
.
1962
Oct
;
207
(
4
):
93
102
.
[PubMed]
0036-8733
50.
Cormier
S
,
Lavigne
GL
,
Choinière
M
,
Rainville
P
.
Expectations predict chronic pain treatment outcomes
.
Pain
.
2016
Feb
;
157
(
2
):
329
38
.
[PubMed]
0304-3959
51.
Haanstra
TM
,
Kamper
SJ
,
Williams
CM
,
Spriensma
AS
,
Lin
CW
,
Maher
CG
, et al.
Does adherence to treatment mediate the relationship between patients’ treatment outcome expectancies and the outcomes of pain intensity and recovery from acute low back pain?
Pain
.
2015
Aug
;
156
(
8
):
1530
6
.
[PubMed]
0304-3959
52.
Mondloch
MV
,
Cole
DC
,
Frank
JW
.
Does how you do depend on how you think you’ll do? A systematic review of the evidence for a relation between patients’ recovery expectations and health outcomes
.
CMAJ
.
2001
Jul
;
165
(
2
):
174
9
.
[PubMed]
0820-3946
53.
Sohl
SJ
,
Schnur
JB
,
Montgomery
GH
.
A meta-analysis of the relationship between response expectancies and cancer treatment-related side effects
.
J Pain Symptom Manage
.
2009
Nov
;
38
(
5
):
775
84
.
[PubMed]
0885-3924
54.
Carvalho
C
,
Caetano
JM
,
Cunha
L
,
Rebouta
P
,
Kaptchuk
TJ
,
Kirsch
I
.
Open-label placebo treatment in chronic low back pain: a randomized controlled trial
.
Pain
.
2016
Dec
;
157
(
12
):
2766
72
.
[PubMed]
0304-3959
55.
Matsuoka
H
,
Yoshiuchi
K
,
Koyama
A
,
Makimura
C
,
Fujita
Y
,
Tsurutani
J
, et al.
Expectation of a Decrease in Pain Affects the Prognosis of Pain in Cancer Patients: a Prospective Cohort Study of Response to Morphine
.
Int J Behav Med
.
2017
Aug
;
24
(
4
):
535
41
.
[PubMed]
1070-5503
56.
Kirsch
I
,
Lynn
SJ
,
Vigorito
M
,
Miller
RR
.
The role of cognition in classical and operant conditioning
.
J Clin Psychol
.
2004
Apr
;
60
(
4
):
369
92
.
[PubMed]
0021-9762
57.
Kessner
S
,
Wiech
K
,
Forkmann
K
,
Ploner
M
,
Bingel
U
.
The effect of treatment history on therapeutic outcome: an experimental approach
.
JAMA Intern Med
.
2013
Aug
;
173
(
15
):
1468
9
.
[PubMed]
2168-6106
58.
Colloca
L
,
Benedetti
F
.
Placebos and painkillers: is mind as real as matter?
Nat Rev Neurosci
.
2005
Jul
;
6
(
7
):
545
52
.
[PubMed]
1471-003X
59.
Klinger
R
,
Flor
H
. Clinical and Ethical Implications of Placebo Effects: Enhancing Patients’ Benefits from Pain Treatment. In:
Benedetti
F
,
Enck
P
,
Frisaldi
E
,
Schedlowski
M
, editors
.
Placebo
.
Berlin, Heidelberg
:
Springer Berlin Heidelberg
;
2014
. pp.
217
35
.
60.
Colloca
L
,
Enck
P
,
DeGrazia
D
.
Relieving pain using dose-extending placebos: a scoping review
.
Pain
.
2016
Aug
;
157
(
8
):
1590
8
.
[PubMed]
0304-3959
61.
Finniss
DG
,
Kaptchuk
TJ
,
Miller
F
,
Benedetti
F
.
Biological, clinical, and ethical advances of placebo effects
.
Lancet
.
2010
Feb
;
375
(
9715
):
686
95
.
[PubMed]
0140-6736
62.
Klinger
R
,
Colloca
L
,
Bingel
U
,
Flor
H
.
Placebo analgesia: clinical applications
.
Pain
.
2014
Jun
;
155
(
6
):
1055
8
.
[PubMed]
0304-3959
63.
Garland
EL
,
Howard
MO
,
Zubieta
JK
,
Froeliger
B
.
Restructuring hedonic dysregulation in chronic pain and prescription opioid misuse: effects of mindfulness-oriented recovery enhancement on responsiveness to drug cues and natural rewards
.
Psychother Psychosom
.
2017
;
86
(
2
):
111
2
.
[PubMed]
0033-3190
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.